ABSTRACT
ABSTRACT Introduction: Congenital heart diseases (CHDs) constitute the most prevalent congenital pathology, and they are a consequence of structural and functional abnormalities during fetal development. The etiology of CHD involves the interaction of genetic and environmental factors. Fetal cardiac surgery aims at preventing natural pathways of CHD in utero, mitigating progression to more complex abnormalities. The goal of this review was to demonstrate the benefits and risks of fetal interventions in the two most prevalent CHDs, pulmonary stenosis and pulmonary atresia with an intact ventricular septum, but also critical aortic stenosis and hypoplastic left heart syndrome. Methods: Original and relevant articles were selected by meta-aggregation to perform a qualitative analysis of fetal cardiac interventions for pulmonary stenosis and critical aortic stenosis. The Joanna Briggs Institute's Qualitative Assessment and Review Instrument (or JBI-QARI) was used for data quality appraisal. Results: Of 61 potential articles, 13 were selected, and nine were finally included. Discussion: The present review demonstrated that fetal cardiac surgery increases right ventricular growth and hemodynamic flow in pulmonary stenosis, whereas in critical aortic stenosis it enables growth of the left ventricle and increases left ventricular pressure. However, it has a high complication rate, along with considerable morbidity and mortality. Conclusion: The benefits of fetal cardiac surgery for pulmonary stenosis and critical aortic stenosis are well-described in the literature; however, there is a significant risk of complications which can be reduced by the surgeon's technical expertise and well-structured hospital facilities.
ABSTRACT
Objetivo: Evaluar la experiencia de 15 años, de la valvuloplastía pulmonar con balón en el Centro Médico Nacional Siglo XXI. Material y métodos: Se estudiaron 150 pacientes 73 (48.7%) masculino y 77 (51.7%) femenino. La edad promedio de los 141 en quienes se realizó la valvuloplastía pulmonar con balón fue de 10.5 ± 11.3 años. Resultados: El gradiente promedio prevalvuloplastía de 86 ± 35 descendió a 21.67 ± 12.20 mm Hg p < .001. La presión sistólica del ventrículo derecho de 106 ± 34.8 mm Hg disminuyó a 53 ± 27 mm Hg p < 0.0001. El gradiente valvular pulmonar en el seguimiento promedio de 48 ± 44 meses fue de 13.43 ± 8.73 mm Hg p < 0.001. Se presentaron complicaciones en 9 (6%) pacientes. Se obtuvo éxito técnico inmediato post en 111 (74%) y fracaso inmediato en 39 (26%). Al final del seguimiento se obtuvo éxito en 104 (89.6%) y fracaso en 12 (10.4%) pacientes, p < 0.0001, con una mortalidad global de 2 (1.33 %) pacientes. Las variables significativas para fracaso fueron: la edad de, 1.5 ± 1.33 años para falla de procedimiento, p < .004; morfología valvular displásica p < 0.001. gradiente valvular pulmonar prevalvuloplastía elevado con p < 0.002 y presión sistólica del ventrículo derecho pre valvuloplastía elevados. p < 0.0001, no descendiendo ambos en el post inmediato. Conclusión: La valvuloplastía pulmonar con balón es el tratamiento de elección, efectivo y seguro de la estenosis valvular pulmonar congénita.
Objective: To evaluate 15 years of experience with balloon pulmonary valvuloplasty in a single third level health care center. Material and methods: Hundred-fifty patients underwent the procedure, 73 (48%) men and 77 (52%) women, mean age 10.5 ± 11.3 years. Results: The initial systolic gradient decreased from 86 ± 35 to 21.67 ± 12.20 mm Hg, p < 0.001, whereas the initial right ventricular systolic pressure decreased from 106 ± 34-8 to 53 ± 27 mm Hg, p < 0.0001. At the end of the follow-up, 48 ± 44 months, the systolic gradient was 13.43 ± 8.73 mm Hg, p < 0.001. Major complications occurred in 9 (6.4%) patients. Immediate technical success was achieved in 111 (74%) patients and failure in 39 (26%). At the end of the follow-up period, successful outcomes were achieved in 104 (89.6%); in contrast, failures were present in 12 (10.4%) patients, p < 0.001. Death occurred in 2 (1.33%) patients. The predictors for failure were age < 1.5 ± 1-33 years (p < 0.004), dysplastic valve (p < 0.001), high initial systolic gradient (p < 0.002), and high initial systolic right ventricular pressure (p < 0.0001). Conclusion: Balloon pulmonary valvuloplasty is an effective, safe, and first choice treatment for congenital pulmonary valve stenosis. (Arch Cardiol Mex 2003; 73:190-196).